Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: ROST stock price vs ELV: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at ELV's multiple
Needs ELV P/E.
Implied fair value · at ROST's multiple
Needs ROST P/E.
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
Nine period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Ross Stores, Inc. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
ELEVANCE HEALTH, INC. · implied price per share
Bear
$158.07
Base
$203.66
Bull
$263.02
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
TJX COMPANIES INC /DE/
ROST vs TJX
Walgreens Boots Alliance, Inc.
ROST vs WBA
NORDSTROM INC
ROST vs JWN
Macy's, Inc.
ROST vs M
DILLARD'S, INC.
ROST vs DDS
TARGET CORP
ROST vs TGT
UnitedHealth Group Incorporated
ROST vs UNH
CVS Health Corporation
ROST vs CVS
HUMANA INC
ROST vs HUM
CENTENE CORP
ROST vs CNC
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe ROST can justify a sustained premium multiple despite slower growth than ELV, then avoid adding aggressively at current levels because the stock already trades well above ELV-implied and DCF ranges; if not, the relative valuation argues for caution or profit-taking.
ROST’s current price of $253.22 is far above ELV-implied value of $102.58, implying -59.5% downside on the stated P/E comparison. The stock also sits well above ELV-implied range, while only modestly aligning with the upper end of its historical band.
Supporting Metrics
